Chris Schelling
2022
In 2022, Chris Schelling earned a total compensation of $834.2K as President and Chief Executive Officer at Opexa Therapeutics, a 51% increase compared to previous year.
Compensation breakdown
| Bonus | $239,800 |
|---|---|
| Option Awards | $94,465 |
| Salary | $500,015 |
| Total | $834,230 |
Schelling received $500K in salary, accounting for 60% of the total pay in 2022.
Schelling also received $239.8K in bonus and $94.5K in option awards.
Rankings
In 2022, Chris Schelling's compensation ranked 3,339th out of 5,505 executives tracked by ExecPay. In other words, Schelling earned more than 39.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,339 out of 5,505 | 39th |
Division Manufacturing | 1,881 out of 2,984 | 37th |
Major group Chemicals And Allied Products | 891 out of 1,339 | 34th |
Industry group Drugs | 831 out of 1,242 | 33rd |
Industry Pharmaceutical Preparations | 602 out of 896 | 33rd |
Source: SEC filing on April 14, 2023.
Schelling's colleagues
We found two more compensation records of executives who worked with Chris Schelling at Opexa Therapeutics in 2022.
News
Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
April 14, 2023
Opexa Therapeutics Chief Business Officer Jefferson Davis receives $635K in 2021
April 15, 2022
Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
April 16, 2021
Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
October 14, 2020
Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
April 12, 2019